Product Description
The Brazilian dental bone graft substitute and other biomaterials market was valued at over $200 million in 2024. This is expected to increase over the forecast period at a CAGR of 14.6% to reach nearly $521 million.
The full report suite on the Brazilian market for dental bone graft substitute (DBGS) and other biomaterials includes DBGSs, dental barrier membranes, local antimicrobial periodontal treatments and dental soft tissue wound care. Collectively, these segments will be referred to as the dental biomaterials market. Allografts are not included in the Brazilian market, as they are banned due to the absence of the necessary governmental regulatory structures.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
BRAZILIAN DENTAL BONE GRAFT SUBSTITUTE MARKET TRENDS
Market growth will be supported by ongoing technological advancements that enable companies to introduce innovative products designed to enhance ease of use and patient comfort. These new product launches expand a company’s portfolio, helping to capture greater market share while supporting stable or increasing ASPs, particularly in innovation-driven segments like the barrier membrane market. As more clinical research continues to validate the benefits of advanced biomaterials, adoption rates for new dental regenerative products are expected to rise steadily.
BRAZILIAN DENTAL BONE GRAFT SUBSTITUTE MARKET SHARE INSIGHTS
- Geistlich Pharma remained the leading competitor in Brazil’s total dental biomaterials market in 2024, holding dominant shares in both the DBGS and dental barrier membrane segments. Its flagship products – Bio-Oss®, a bovine-derived xenograft, and Bio-Gide®, a resorbable collagen membrane – continue to be widely regarded as the gold standard in regenerative dental procedures. In 2024, Geistlich further solidified its market position through the acquisition of Bionnovation Biomedical, a Brazilian company that ranked third in the dental biomaterials market that year. This strategic acquisition expands Geistlich’s product offerings and enhances its local manufacturing capabilities. Although rising competition from regional manufacturers offering more affordable alternatives is anticipated, Geistlich is expected to maintain its leadership in the DBGS market over the forecast period.
- Straumann Group was the second-leading competitor in 2024. Due to its partnership with botiss, Straumann Group was also able to enter the dental barrier membrane market and gain significant market share. This boasted its product line and strengthened its position in the total market in Brazil. The company’s strong reputation and loyal customer base permitted easy access for its salesforce to promote its dental biomaterials. Straumann Group is strengthened by a stable operational structure and a consistent, wide product portfolio with a reputation for quality.
- Critéria was another leading competitor in the total Brazilian dental biomaterials market. It was the second-leading competitor within the xenograft market, being one of the local companies that was able to provide inexpensive products that compete with traditional xenografts such as those offered by Geistlich. Critéria products are up to 60% less expensive than the main competitors abroad. The company is best known for its Lumina-Bone® and Lumina-Porous® xenograft Aside from its cost-effective appeal, Lumina-Bone® was able to attract customers through its aesthetic appeal. In January 2024, Criteria Biomateriais was acquired by Maquira Dental Group. This strategic move aims to strengthen Maquira’s position in the dental biomaterials market by integrating Criteria’s 30 years of expertise in research and product development. The acquisition is expected to enhance Maquira’s portfolio with advanced bone graft substitutes and regenerative solutions, further expanding its reach in the dental industry.
MARKET SEGMENTATION SUMMARY
- Dental Bone Graft Substitutes – Further Segmented Into:
- Type: Allografts, Xenografts, and Synthetics.
- Dental Barrier Membranes – Further Segmented Into:
- Type: Resorbable and Non-Resorbable Membranes.
- Material: Xenografts and Synthetics.
- Antimicrobial Periodontal Treatment
- Dental Soft Tissue Wound Care – Further Segmented Into:
- Type: Plugs, Tape, and Foam.
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | Brazil |
| Base Year | 2024 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Data | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
